Screening and diagnosis of HBV in low-income and middle-income countries

JP Allain, O Opare-Sem - Nature reviews Gastroenterology & …, 2016 - nature.com
HBV testing and diagnosis of HBV-related liver disease in low-income and middle-income
countries differs substantially from that in developed countries in terms of access to …

Challenges in hepatitis B detection among blood donors

JP Allain, L Cox - Current opinion in hematology, 2011 - journals.lww.com
HBV blood safety is improved by NAT for HBV DNA when applied to individual donations.
Until the sensitivity of NAT is improved, both this method and HBsAg screening are needed …

Viral hepatitis in India

P Abraham - Clinics in laboratory medicine, 2012 - labmed.theclinics.com
Viral hepatitis is a major public health problem in India, caused mainly by hepatitis viruses A
through E. 1 Though both of the enterically transmissible viruses, hepatitis A virus (HAV) and …

Occult hepatitis infection in transfusion medicine: screening policy and assessment of current use of anti-HBc testing

A Esposito, C Sabia, C Iannone, GF Nicoletti… - Transfusion Medicine …, 2017 - karger.com
HBV still represents a global risk factor in transfusion medicine. The residual risk of HBV is
not limited to pre-seroconversion window period but it extends to donors with occult HBV …

Antibodies to Hepatitis B core antigen prevalence study in Kazakhstan

T Savchuk, Y Grinvald, M Ali… - Immunity …, 2023 - Wiley Online Library
Introduction Kazakhstan is being considered medium‐endemic for Hepatitis B virus infection
(HBV). HBV remains transmissible by direct exposure to infected blood or organic fluids …

[HTML][HTML] Global epidemiology of occult HBV infection

JP Allain - Annals of Blood, 2017 - aob.amegroups.org
Defining the epidemiology of occult HBV infection (OBI) is difficult because it relies on
disparate sets of data and on the respective performance of both hepatitis B surface antigen …

Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors

G Karimi, M Zadsar, N Vafaei, Z Sharifi, M FalahTafti - Virology journal, 2016 - Springer
Background Hepatitis B virus is one of the most important blood born viruses. Although the
sensitivity of screening tests has been considerably increased, transmission may still occur …

Hepatitis B virus nucleic acid amplification testing of A ustralian blood donors highlights the complexity of confirming occult hepatitis B virus infection

P Kiely, AR Margaritis, CR Seed, H Yang… - …, 2014 - Wiley Online Library
Background We present an analysis of the first 2 years of hepatitis B virus (HBV) nucleic acid
testing (NAT) of the A ustralian donor population. Study Design and Methods Between J uly …

INASL guidelines on management of hepatitis B virus infection in patients receiving chemotherapy, biologicals, immunosupressants, or corticosteroids

A Arora, AC Anand, A Kumar, SP Singh… - Journal of clinical and …, 2018 - Elsevier
Hepatitis B Virus (HBV) reactivation in patients receiving chemotherapy, biologicals,
immunosupressants, or corticosteroids is emerging to be an important cause of morbidity …

[PDF][PDF] Prevalence of Hepatitis B Virus (HBV) among blood donors in Eastern Saudi Arabia: results from a five-year retrospective study of HBV seromarkers

FM Alzahrani, SS Shaikh, AI Alomar… - Annals of laboratory …, 2019 - synapse.koreamed.org
Background: Transfusion-transmissible hepatitis B virus (HBV) infection is a major problem
worldwide. Recently, confirmatory nucleic acid tests (NATs) for HBV DNA have been …